What Precision Dose, Inc. does

Precision Dose, Inc. is a privately held pharmaceutical company founded in 2003 and headquartered in South Beloit, Illinois. The company manufactures and packages unit-dose oral medications in three primary delivery formats: individual unit-dose cups for liquid formulations (solutions, syrups, suspensions), pre-filled oral syringes with ENFit connectors, and unit-dose tablets/capsules, with a secondary line of sterile injectable medications including Dexmedetomidine, Levetiracetam, Lidocaine, and Phentolamine. Its core packaging technology integrates NDC bar coding on every unit, custom molded cup geometry compatible with automated dispensing machines, color-differentiated labeling, and USP-compliant release testing for chemical and microbial integrity.

The company serves two primary vertical markets: institutional healthcare (hospitals, nursing homes, prisons, rehabilitation facilities) and retail (chain stores, pharmacies, food/drug retailers). Products reach end customers through the four largest US healthcare wholesalers — Cardinal Health, Cencora, McKesson, and Morris Dickson. Pricing is structured on a per-unit basis (case quantities of 30, 50, or 100 units) with no publicly disclosed list prices; quotes are obtained via distributors or direct contact. The company supplements its organic product development with an active partnership program targeting CDMOs, CMOs, and CROs for licensing, co-development, and ANDA acquisitions, particularly in injectable and niche formulations.

The business is founder-led, with Robert Koopman serving as President and Valerie Koopman as VP of Product Development. Leadership is organized around functional VPs covering Sales/Marketing, Procurement/IT, and Quality/Regulatory. There are no disclosed external investors, venture funding, or private equity involvement, and no public listing. In 2025, the company expanded into the retail segment by reintroducing subsidiary products under the Precision Dose label, launching a series of new SKUs (including controlled substances such as Morphine Sulfate CII oral solution) and maintaining a forward calendar of industry trade shows (NACDS Total Store Expo, HCP Hospital Pharmacy Conference) extending into 2026.

Name

Precision Dose, Inc.

Legal name

Precision Dose, Inc.

Website

https://precisiondose.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

Precision Dose is a privately held US pharmaceutical manufacturer founded in 2003, specializing in unit-dose oral medications (cups, pre-filled ENFit syringes, tablets, capsules) and select injectables, distributed through Cardinal, Cencora, McKesson, and Morris Dickson to hospitals, nursing homes, prisons, and retail pharmacies.

Ownership category

akta.pro rank

Product category

Unit-dose Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers) (IMALAIAH), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA)

Keywords

• Unit-dose pharmaceuticals
• Oral liquid medications
• Pre-filled oral syringes
• Pharmaceutical packaging
• Institutional medications

Headquarters

HQ city

South Beloit

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling unit-dose pharmaceuticals, OTC medicines, and dietary supplements through B2B distribution channels serving institutional and retail healthcare markets.
2. Licensing and ANDA Acquisitions: Revenue stream through licensing arrangements, co-development partnerships, and acquisition of Abbreviated New Drug Applications (ANDAs) to expand product portfolio.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Precision Dose manufactures and packages pharmaceutical products in unit-dose formats, including liquid oral medications in unit-dose cups, pre-filled ENFit oral syringes, unit-dose tablets and capsules, and injectable medications. The company sells these primarily to institutional healthcare facilities (hospitals, nursing homes, prisons, rehabilitation centers) and retail pharmacies through major healthcare distributors.

Product overview

Precision Dose is a pharmaceutical packaging company specializing in unit-dose medication delivery for institutional and retail markets. The company offers three primary product delivery systems: unit-dose cups for liquid medications (solutions, syrups, suspensions), pre-filled oral syringes with ENFit connectors, and unit-dose tablets/capsules. Additional offerings include injectable medications. The company recently expanded into retail markets. Key product features include individual barcoding (NDC number) on all packaging, custom molded cups for dispensing machine compatibility, and release testing for chemical and microbial integrity. Products serve acute care markets including hospitals, nursing homes, prisons, and rehabilitation facilities, as well as retail chain stores and pharmacies.

Differentiator

Problem solved

Functional benefit

Products and services

• Unit-Dose Oral Cups Liquid medications packaged in individual unit-dose cups in various sizes (5mL, 10mL, 20.3mL) for accurate dosage delivery in institutional settings. Each cup is individually barcoded with the NDC number.
• Pre-Filled Oral Syringes (ENFit) Pre-filled oral syringes with ENFit connectors for precise medication delivery, available in various volumes and formulations including controlled substances such as Morphine Sulfate, Clobazam, Glycopyrrolate, and Acetaminophen.
• Unit-Dose Tablets and Capsules Individual barcoded tablets and capsules in various dosages, packaged as unit-dose for hospitals, nursing homes, and institutional use.
• Injectable Medications Sterile injectable medications including Dexmedetomidine HCl, Levetiracetam, Lidocaine HCl, and Phentolamine Mesylate for institutional use.
• Retail Pharmaceuticals Pharmaceutical tablets for retail pharmacies and chain stores, including antibiotics (Azithromycin), anticonvulsants (Gabapentin), diabetes medications (Metformin), and cholesterol-lowering Cholestyramine in various dosage strengths.
• Liquid Multivitamin/Multimineral Supplement Oral liquid vitamin and mineral supplement in 15mL unit-dose cups for nutritional supplementation.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• CDMOs (Contract Development and Manufacturing Organizations)coreStrategic or Co-development PartnerPrecision Dose partners with CDMOs for product development and manufacturing, particularly in niche areas including injectables. The company actively seeks these partnerships to expand its diverse product portfolio and strengthen manufacturing capabilities.
• CMOs (Contract Manufacturing Organizations)coreStrategic or Co-development PartnerPartnerships with CMOs enable Precision Dose to leverage external manufacturing expertise and capacity for pharmaceutical production, supporting the company's growth strategy and product portfolio expansion.
• CROs (Contract Research Organizations)coreStrategic or Co-development PartnerPrecision Dose collaborates with CROs for development initiatives, regulatory support, and ANDA acquisition activities to strengthen its pipeline of products in development.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lannett Company: US generic pharmaceutical manufacturer producing oral solid and liquid generics sold through wholesalers to retail and institutional customers. Comparable to Precision Dose on generic unit-dose positioning, reliance on Big-3 wholesalers, and specialty/generic mix.
• Padagis: Specialty generics manufacturer focused on differentiated oral, topical, and unit-dose pharmaceutical products sold through retail and institutional channels. Highly comparable to Precision Dose on customer base, generic unit-dose formulations, and channel distribution model.
• Mallinckrodt Pharmaceuticals: Specialty pharmaceutical manufacturer with a strong unit-dose and oral-liquid portfolio for hospital and institutional customers, including controlled substances. Closely comparable to Precision Dose on dosage form, customer segment (hospitals, institutional), and unit-dose packaging expertise.
• West Pharmaceutical Services: Global pharmaceutical packaging and delivery specialist producing stoppers, seals, syringes, and device components for injectables and oral medicines. Comparable to Precision Dose because both operate at the intersection of pharmaceutical packaging, containment, and drug-delivery formats that hospitals and pharma manufacturers require.

Others

• Cardinal Health: Major US pharmaceutical distributor and one of Precision Dose's primary channel partners, also offering proprietary private-label generic and unit-dose products through its Medical and Pharmaceutical segments. Included for channel-adjacency: as both the dominant partner for Precision Dose products and a potential competitor in unit-dose private label.

Broad incumbents

• Amneal Pharmaceuticals: Large US generic pharmaceutical manufacturer with diverse dosage-form portfolio (oral liquids, injectables, topicals) sold via all major wholesalers to both institutional and retail channels. Comparable to Precision Dose on product formats, GPO/wholesaler distribution, and generic unit-dose positioning.
• Becton Dickinson (BD): Large medical-technology manufacturer with a significant pharmaceutical systems and drug-delivery portfolio, including pre-filled syringes and ENFit-compatible devices. Overlaps with Precision Dose on unit-dose oral syringes and broader hospital medication-delivery formats, though BD operates as a much broader medtech incumbent.
• Gerresheimer: Global producer of pharmaceutical primary packaging (glass vials, ampoules, syringes, plastic containers) serving pharma and biotech customers. Comparable to Precision Dose's unit-dose packaging and injectable container formats, with overlap on hospital and retail drug-delivery packaging.
• Catalent: Global CDMO providing development, manufacturing, and packaging services for oral, injectable, and biologic pharmaceuticals. Comparable to Precision Dose's CMO/CDMO partnership model and unit-dose/sterile manufacturing formats, although Catalent operates as a contract manufacturer rather than a finished-dose brand owner.
• Hikma Pharmaceuticals: Multinational generic and specialty pharmaceutical manufacturer with a strong hospital-focused unit-dose and injectable portfolio. Comparable to Precision Dose on hospital-customer orientation, oral-liquid and injectable generics, and unit-dose packaging expertise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/precision-dose-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision Dose, Inc.